<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers
2023 · Science · 550 citations
https://doi.org/10.1126/science.ade2292
W
Whijae Roh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
117
Papers
4.8K
Citations
15
h-index
17
i10-index
Whijae Roh is an academic researcher from Pfizer (United States). The author has contributed to research in topics: RNA modifications and cancer & Ferroptosis and cancer prognosis & Cancer Genomics and Diagnostics. The author has an h-index of 15, co-authored 100 publications.
ORCID: 0000-0002-7395-9939Papers by this author
worksThe Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
2020 · Cancer Discovery · 221 citations
https://doi.org/10.1158/2159-8290.cd-19-1500
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety
2025 · Cancer Cell · 35 citations
https://doi.org/10.1016/j.ccell.2025.02.006
Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma
2020 · Nature Communications · 26 citations
https://doi.org/10.1038/s41467-020-15538-9
Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4/6 inhibitors
2025 · Nature Communications · 10 citations
https://doi.org/10.1038/s41467-025-55914-x
Additional file 1 of Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13192515
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat